Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis

Osteoporosis International

Volumn 8, Issue 2, 1998, Pages 121-126

  Fraser, W D ^a   Logue, F C ^b   Christie, J P ^b   Gallacher, S J ^b   Cameron, D ^b   O'Reilly, D St J ^b   Beastall, G H ^b   Boyle, I T ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Circadian rhythm; Osteoporosis; Parathyroid hormone; Phosphate

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; BLOOD SAMPLING; BONE REMODELING; CALCIUM METABOLISM; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; POSTMENOPAUSE OSTEOPOROSIS; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 0031961633     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02672507     Document Type: Article

References (50)

1. Nussbaum SR, Zahradrick RJ, Lavigne JR, et al. Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcaemia. Clin Chem 1987;33:1364-7.
2. Brown RC, Aston JP, Weeks I, Woodhead JS. Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay. J Clin Endocrinol Metab 1987;65:407-14.
3. Logue FC, Perry B, Chapman RS, Milne I, James K, Beastall GH. A two-site immunoradiometric assay for FTH (1-84) using N and C terminal specific monoclonal antibodies. Ann Clin Biochem 1991;28:160-6.
4. Logue FC, Fraser WD, O'Reilly DStJ, Beastall GH. The circadian rhythm of intact parathyroid hormone and nephrogenous cyclic adenosine monophosphate in normal men. J Endocrinol 1989;121:R1-3.
5. Calvo MS, Eastell R, Offord KP, Bergstralh EJ, Burritt MF. Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis. J Clin Endocrinol Metab 1991;72:69-76.
6. Harms HM, Kaptaina V, Kulpmann WR, Brabant G, Hesch RD. Pulse amplitude and frequency modulation of parathyroid hormone in plasma. J Clin Endocrinol Metab 1989;69:843-51.
7. Logue FC, Fraser WD, O'Reilly DStJ, Cameron DA, Kelly AJ, Beastall GH. The circadian rhythm of intact parathyroid hormone (1-84): temporal correlation with prolactin secretion in normal men. J Clin Endocrinol Metab 1991;71:1556-60.
8. Nielsen HK, Laurberg P, Brixen K, Mosekilde L. Relations between diurnal variations in serum osteocalcin, cortisol, parathyroid hormone and ionised calcium in normal individuals. Acta Endocrinol 1991;124:391-8.
9. Logue FC, Fraser WD, Gallacher SJ, et al. The loss of circadian rhythm for intact parathyroid hormone and nephrogenous cyclic AMP in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 1990;32:475-83.
10. Lobaugh B, Neelon FA, Oyama H, et al. Circadian rhythms for calcium, inorganic phosphorus and parathyroid hormone in primary hyperparathyroidism: functional and practical considerations. Surgery 1989;106:1009-17.
11. Gallacher SJ, Fraser WD, Logue FC, et al. The loss of diurnal rhythm of PTH secretion in untreated psuedohypoparathyroidism. Bone 1991;12:297.
12. Calvo MS, Kumar R, Heath H III. Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods. J Clin Endocrinol Metab 1988;66:823-9
13. Fraser WD, Logue FC, Christie JP, et al. Alteration of the circadian rhythm of intact parathyroid hormone following a 96-hour fast. Clin Endocrinol 1994;40:523-8.
14. Eastall R, Calvo MS, Burritt MF, Offord KP, Russell GG, Riggs BL. Abnormalities in circadian patterns of bone resorption and renal calcium conservation m type I osteoporosis. J Clin Endocrinol Metab 1992;74:487-94.
15. Gallagher J, Riggs B, Jerpbak C, Arnaud C. The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women. J Lab Clin Med 1980;95:373-85.
16. Teitelbaum S, Rosenberg E, Richardson C, Avioli L. Histologic studies of bone from normocalcemic postmenopausal women with increased circulating parathyroid hormone levels. J Clin Endocrinol Metab 1976;42:537-43.
17. Cicitelli R, Agnusdei D, Nardi P, et al. Effect of one year's treatment with estrogens on bone mass, intestinal calcium absorption and 25-hydroxyvitamin D 1α-hydroxylase reserve in postmenopausal osteoporosis. Calcif Tissue Im 1988;42:76-86.
18. Bouillon R, Geusens P, Dequeker J, DeMoor P. Parathyroid function in primary osteoporosis. Clin Sci 1979;578:167-71.
19. Rigas B, Ryan R, Wahner H, et al. Serum concentration of estrogen, testosterone and gonadotropins in osteoporotic and nonosteoporotic postmenopausal women. J Clin Endocrinol Metab 1973;36:1097-9
20. Gallagher J, Riggs B, Eisman J, Hamstra A, Arnaud S, DeLuca H. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J Clin Invest 1979;66:729.
21. Sorenson O, Lumholtz B, Lund B, et al. Acute effects of parathyroid hormone on vitamin D metabolism in patients with the bone loss of aging. J Clin Endocrinol Metab 1981;54:1258-61.
22. Kotowicz M, Klee G, Kao P, et al. Relationship between serum intact PTH and bone remodelling in type I osteoporosis: evidence that skeletal sensitivity is increased. Osteoporos Int 1990;1:14-20.
23. Cosman F, Shen V, Herrington B, Lindsay R. Responses of the parathyroid gland to infusion of human parathyroid hormone (1-34). J Clin Endocrinol Metab 1991;73:1345-51.
24. Ebeling P, Jones J, Burritt M, et al. Skeletal responsiveness to endosenous parathyroid hormone in postmenopausal osteoporosis. J Clin Endocrinol Metab 1992;75:1033-8.
25. Reeve J, Davies UM, Hesp R, McNally E, Katz D. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. BMJ 1990;301:314-8
26. Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM. An evaluation of several biochemical markers for bone formation and resorption m a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. J Clin Invest 1993;91:1138-48.
27. Podbesek R, Edonard L, Meunier P, et al. Effects of two treatment regimens with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 1983;112:1000-6.
28. Malluche H, Sherman D, Meyer W, Ritz E, Norman A, Massry S. Effects of long-term infusion of physiological doses of 1-34 PTH on bone. Am J Physiol 1982;242:197-201.
29. Gallacher SJ, Fenner JAK, Anderson K, et al. Intravenous pamidronate in the treatment of corticosteroid dependent lung disease: an open pilot study. Thorax 1992;47:932-6.
30. Gardner MD, Dryburgh FJ, Fyffe JA, Jenkins AS. Predictive value of derived figures based on the measurement of ionised calcium. Ann Clin Biochem 1981;81:106-9.
31. Nelson W, Tong YL, Lee JK, Halberg F. Methods for cosinor rhythmometry. Chrononbiological 1979;6:305-23.
32. Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med 1986;314:1676-86.
33. McKenna MJ, Frame B. Hormonal influences on osteoporosis. Am J Med 1987;82(Suppl 1B):61-7.
34. Scherman SS, Hollis BW, Tobin JD. Vitamin D status and related parameters in a health population, the effects of age, sex and season. J Clin Endocrinol Metab 1990;71:405-13.
35. Eastall R, Simmons PS, Colwell A, et al. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyndinoline excretion: effects of growth and ageing. Clin Sci 1992;83:375-82.
36. Raisz LG. Bone resorption m tissue culture: factors influencing the response to parathyroid hormone. J Clin Invest 1965;44:103-16.
37. Ibbotson KJ, Roodman GD, McManus LM, Mundy GR. Identification and characterisation of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells. J Cell Biol 1984:99:471-80.
38. Dietrech HW, Canalis EM, Maina DM, Raisz LG. Hormonal control of bone collagen synthesis in vitro: effects of parathyroid hormone and calcitonin. Endocrinology 1976;98:943-9.
39. Kripke DF, Lavie P, Parker D, Huey L, Deftos LJ. Plasma parathyroid hormone and calcium are related to sleep cycles. J Clin Endocrinol Metab 1978;47:1021-7.
40. Logue FC, Fraser WD, O'Reilly DStJ. et al. Sleep shift dissociates the nocturnal peaks of parathyroid hormone (1-84), nephrogenous cyclic adenosine monophosphate and prolactin in normal men. J Clin Endocrinol Metab 1992;75:25-9.
41. Markowitz ME, Arnaud S, Rosen JF, Thorpy M, Laximinarajan S. Temporal interrelationships between circadian rhythms of serum parathyroid hormone and calcium concentrations. J Clin Endocrinol Metab 1988;67:1068-73.
42. Mallete LE, Kirkland JL. Fine regulation of serum calcium: acute midday decreases in calcium ion concentration trigger a parathyroid response. In: Cohn DV, Fujita T, Potts JT Jr, editors. Endocrine control of bone and calcium metabolism, vol 8A. New York: Elsevier, 1984:71-88.
43. Perry HM, Province MA, Droke DM, Kim GS, Shaheb S, Avioli LV. Diurnal variation of serum calcium and phosphorus in postmenopausal women. Calcif Tissue Int 1986;38:115-8.
44. Jubiz W, Canterbury JM, Reiss JM, Tyler FM. Circadian rhythm in serum parathyroid hormone concentrations in human subjects: correlation with serum calcium, phosphate, albumin and growth hormone levels. J Clin Invest 1972;51:2040-6.
45. Reiss E, Canterbury JM, Bercovitz MA, Kaplan EL. The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest 1970;49:2146-9.
46. Silverberg SJ, Shane E, Clemens TL, et al. The effect of oral phosphate administration on major indices of skeletal metabolism in normal subjects J Bone Miner Res 1986;1:383-8.
47. Karkkainen M, Lamberg-Allardt C. An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women. J Bone Miner Res 1996;11:1905-12.
48. Calvo MS, Kuman R, Heath H III. Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets. J Clin Endocrinol Metab 1990;70:1334-40.
49. Fine A, Cox D, Fontaine B. Elevation of serum phosphate affects parathyroid hormone levels in only 50% of hemodialysis patients, which is unrelated to changes in serum calcium. J Am Soc Nephrol 1993;3:1947-53
50. Marks KH, Kilav R, Naveh-Many T, Silver J. Calcium, phosphate, vitamin D and the parathyroid. Pediatr Nephrol 1996;10:364-7.